Filing Details
- Accession Number:
- 0001209191-18-046825
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-15 16:47:57
- Reporting Period:
- 2018-06-19
- Accepted Time:
- 2018-08-15 16:47:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1660334 | Verrica Pharmaceuticals Inc. | VRCA | Pharmaceutical Preparations (2834) | 463137900 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741968 | Chris Degnan | C/O Verrica Pharmaceuticals Inc. 10 North High Street, Suite 200 West Chester PA 19380 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-19 | 3,000 | $15.00 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
